Clinical Trial Update: Fluticasone Furoate Treatment of Daytime Somnolence and Cognitive Performance in Seasonal Allergic Rhinitis [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update evaluating Fluticasone Furoate for daytime somnolence and cognitive performance in seasonal allergic rhinitis; results have been p…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Seasonal Allergic Rhinitis

Drugs mentioned

• Fluticasone Furoate (fluticasone furoate)

Snippet

Sponsor: Western Sky Medical Research | Conditions: Seasonal Allergic Rhinitis | Phase 4 | Status: COMPLETED | Results posted: 2018-05-18